A good recovery in the last hour of trade helped D-Street cut big losses and end August series on a slightly better note. However,
the Nifty managed to close below 11,700-mark
.
A weak rupee weighed on indices through the day, with the Indian currency dropping to a fresh low of 70.8550. Analysts had attributed the fall to rising crude oil prices and month-end dollar buying by oil companies to pay these off.
Among sectors, FMCG, metals and pharma along with PSU banks were the top gainers, while auto, energy and
Bank Nifty were the big laggards. In the broader markets,
the Nifty Midcap index, too, ended over one-fifth of a percent higher.
At the close of market hours,
the Sensex ended lower by 32.83 points or 0.08% at 38690.10, while
the Nifty was down 12.20 points or 0.10% at 11679.70.
The market breadth was positive as 1,441 shares advanced, against a decline of 1,255 shares, while 169 shares were unchanged.
HEADLINES OF THE DAYTCS to buy back up to Rs7cr shares from Sept. 6-21.
Cadila gets two final USFDA approvals.
Laurus Labs gets USFDA nod for Metformin Hydrochloride Tablets USP.
The crucial resistance for
Nifty spot is now seen at 11760 and above this 11840. Support for the immediate term is now placed at 11620 next support will be 11550.
